PARAMETRIC PORTFOLIO ASSOCIATES LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$12,183,000
+218.2%
339,347
+106.4%
0.01%
+200.0%
Q4 2021$3,829,000
+33.6%
164,396
+9.0%
0.00%0.0%
Q3 2021$2,866,000
-6.5%
150,788
-0.8%
0.00%0.0%
Q2 2021$3,065,000
+51.4%
152,030
+37.6%
0.00%
+100.0%
Q1 2021$2,024,000
+0.2%
110,486
+10.0%
0.00%0.0%
Q4 2020$2,020,000
-7.9%
100,459
-14.1%
0.00%
-50.0%
Q3 2020$2,193,000
-14.6%
116,968
+2.3%
0.00%0.0%
Q2 2020$2,569,000
+101.3%
114,380
+33.0%
0.00%
+100.0%
Q1 2020$1,276,000
-44.7%
85,969
-28.1%
0.00%
-50.0%
Q4 2019$2,307,000
-25.7%
119,606
-23.6%
0.00%
-33.3%
Q3 2019$3,106,000
-14.3%
156,648
-8.7%
0.00%0.0%
Q2 2019$3,624,000
+12.8%
171,656
+9.1%
0.00%0.0%
Q1 2019$3,214,000
-20.8%
157,332
-22.8%
0.00%
-25.0%
Q4 2018$4,056,000
+82.0%
203,827
+76.0%
0.00%
+100.0%
Q3 2018$2,228,000
+136.3%
115,806
+87.4%
0.00%
+100.0%
Q2 2018$943,000
-33.1%
61,792
-17.8%
0.00%0.0%
Q1 2018$1,409,000
+2.8%
75,132
+5.5%
0.00%0.0%
Q4 2017$1,370,000
+57.1%
71,182
+45.9%
0.00%0.0%
Q3 2017$872,000
+7.0%
48,791
+7.0%
0.00%0.0%
Q2 2017$815,000
+111.7%
45,615
+72.0%
0.00%0.0%
Q1 2017$385,000
-67.4%
26,524
-58.6%
0.00%
-50.0%
Q4 2016$1,182,000
+0.1%
64,145
+3.1%
0.00%0.0%
Q3 2016$1,181,000
+27.8%
62,233
+8.5%
0.00%
+100.0%
Q2 2016$924,000
+64.7%
57,345
+22.6%
0.00%0.0%
Q1 2016$561,000
-6.2%
46,769
+11.3%
0.00%0.0%
Q4 2015$598,000
+219.8%
42,038
+162.6%
0.00%
Q3 2015$187,00016,0090.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders